Order Article Reprints

Ranallo N, Iamurri AP, Foca F, Liverani C, De Vita A, Mercatali L, Calabrese C, Spadazzi C, Fabbri C, Cavaliere D, et al. Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis. Cancers. 2022; 14(13):3231. https://doi.org/10.3390/cancers14133231

Ranallo, Nicoletta, Andrea Prochoswski Iamurri, Flavia Foca, Chiara Liverani, Alessandro De Vita, Laura Mercatali, Chiara Calabrese, Chiara Spadazzi, Carlo Fabbri, Davide Cavaliere, and et al. 2022. "Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis" Cancers 14, no. 13: 3231. https://doi.org/10.3390/cancers14133231

Ranallo, N., Iamurri, A. P., Foca, F., Liverani, C., De Vita, A., Mercatali, L., Calabrese, C., Spadazzi, C., Fabbri, C., Cavaliere, D., Galassi, R., Severi, S., Sansovini, M., Tartaglia, A., Pieri, F., Crudi, L., Bianchini, D., Barone, D., Martinelli, G., ... Bongiovanni, A. (2022). Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis. Cancers, 14(13), 3231. https://doi.org/10.3390/cancers14133231